The novel treatment of the medication represents a exciting advance in the management of the condition. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide422509.losblogos.com/40697802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment